Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A …
Aims To evaluate the efficacy and cardiovascular outcomes of combination pioglitazone with
either a glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) or a sodium‐glucose …
either a glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) or a sodium‐glucose …